Skip to main content

Find Clinical Trials

Home
Conditions
Lymphoma, T-Cell, Peripheral

Clinical trial condition

Lymphoma, T-Cell, Peripheral

Explore clinical trials studying Lymphoma, T-Cell, Peripheral. Study availability and eligibility vary by location and protocol.

235 public trials 60 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, T-Cell, Peripheral trial results

Completed

Bortezomib and Azacitidine in Treating Patients With Relapsed or Refractory T-Cell Lymphoma

NCT01129180

Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +35 more
Locations: Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

CHO(E)P-14 Followed by Alemtuzumab Consolidation in Peripheral T Cell Lymphoma

NCT01806337

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Not specified

View Trial Details

Completed

Gossypol, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

NCT00891072

Conditions: Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Blood Protein Disorders, +121 more
Locations: Cancer Institute of New Jersey New Brunswick, New Jersey, United States

View Trial Details

Completed

Phase I Study of KW-0761 in Relapsed Patients With CCR4-Positive ATL and PTCL

NCT00355472

Conditions: Adult Peripheral T-Cell Lymphoma (PTCL), Adult T-Cell Leukemia and Lymphoma (ATL), Hematologic Diseases, +15 more
Locations: Tokyo, Japan

View Trial Details

Completed

Intensive Chemo-immunotherapy as First Line Treatment in Adult Patients With Peripheral T- Cell Lymphoma

NCT01679860

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Spedali Civili di Brescia Brescia, Italy

Azienda Ospedale Vittorio Emanuele Ferrarorro S. Bambino- Università di Catania Catania, Italy

Ospedale San Carlo Potenza, Italy

Azienda Ospedaliera S. Luigi Orbassano, Torino, Italy

View all 17 locations

View Trial Details

Completed

Phase II Study of ZIO-101 in Advanced Blood and Bone Marrow Cancers

NCT00421213

Conditions: Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +14 more
Locations: Miami, Florida, United States

Chicago, Illinois, United States

Bethesda, Maryland, United States

Fargo, North Dakota, United States

View Trial Details

Completed

The Effectiveness of Alemtuzumab Given in Combination With CHOP and ESHAP in Patients Newly Diagnosed With Peripheral T-Cell Lymphoma (PTCL)

NCT00930605

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: King Chulalongkorn Memorial Hospital Bangkok, Thailand

View Trial Details

Completed

A Nordic Phase II Study of PTCL Based on Dose-intensive Induction and High-dose Consolidation With ASCT

NCT00791947

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Aarhus University Hospital Aarhus, Denmark

Copenhagen Hospital Copenhagen, Denmark

Vejle Hospital Vejle, Denmark

OULO University Hospital Oulu, Oulo, Finland

View Trial Details

Completed

High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin Lymphoma

NCT01177371

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Megakaryoblastic Leukemia (M7), +136 more
Locations: Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Bortezomib and CHOP in Patients With Advanced Stage Aggressive T Cell or Natural Killer (NK)/T Cell Lymphomas

NCT00374699

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations: Samsung Medical Center Seoul, South Korea

View Trial Details